Consolidated Statement Of Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7362167

Concept 2023-03-01 to
2023-11-30
2022-03-01 to
2022-11-30
Consolidated statement of income
Statement of income
Net sales
102,827,000,000 JPY
91,881,000,000 JPY
Ordinary income
Other operating income
Share of profit of entities accounted for using equity method
83,000,000 JPY
JPY
Cost of sales
44,227,000,000 JPY
39,100,000,000 JPY
Ordinary expenses
Other operating expenses
Share of loss of entities accounted for using equity method
JPY
35,000,000 JPY
Operating expenses
Selling, general and administrative expenses
46,330,000,000 JPY
44,274,000,000 JPY
Operating expenses
Gross profit (loss)
58,600,000,000 JPY
52,781,000,000 JPY
Operating profit (loss)
12,270,000,000 JPY
8,506,000,000 JPY
Net sales
Ordinary profit (loss)
16,661,000,000 JPY
13,003,000,000 JPY
Extraordinary income
1,000,000 JPY
142,000,000 JPY
Gain on disposal of non-current assets
1,000,000 JPY
142,000,000 JPY
Non-operating income
4,472,000,000 JPY
4,687,000,000 JPY
Dividend income
705,000,000 JPY
626,000,000 JPY
Interest income
1,806,000,000 JPY
398,000,000 JPY
Cost of sales
Selling, general and administrative expenses
Non-operating income
Other
431,000,000 JPY
452,000,000 JPY
Extraordinary losses
3,000,000 JPY
116,000,000 JPY
Loss on disposal of non-current assets
3,000,000 JPY
116,000,000 JPY
Non-operating expenses
Interest expenses
12,000,000 JPY
12,000,000 JPY
Other
21,000,000 JPY
46,000,000 JPY
Non-operating expenses
80,000,000 JPY
189,000,000 JPY
Profit (loss) before income taxes
16,659,000,000 JPY
13,029,000,000 JPY
Gross profit
Extraordinary income
Extraordinary losses
Income taxes
4,179,000,000 JPY
3,208,000,000 JPY
Profit (loss)
12,480,000,000 JPY
9,821,000,000 JPY
Profit (loss) attributable to non-controlling interests
370,000,000 JPY
299,000,000 JPY
Profit (loss) attributable to owners of parent
12,110,000,000 JPY
9,522,000,000 JPY
Profit attributable to
Other comprehensive income
Valuation difference on available-for-sale securities
4,644,000,000 JPY
2,928,000,000 JPY
Foreign currency translation adjustment
10,795,000,000 JPY
18,021,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
92,000,000 JPY
-31,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-140,000,000 JPY
-240,000,000 JPY
Other comprehensive income
15,391,000,000 JPY
20,678,000,000 JPY
Comprehensive income
27,871,000,000 JPY
30,499,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
27,392,000,000 JPY
30,104,000,000 JPY
Comprehensive income attributable to non-controlling interests
479,000,000 JPY
395,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.